Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

Similar documents
REVISION OF MONOGRAPH ON TABLETS. Tablets

LAB.2. Tablet Production Methods

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation

FDB FOOD AND DRUGS BOARD G H A N A GUIDELINES FOR CONDUCTING BIOEQUIVALENCE STUDIES

Available online through

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

The unlocked synergy of DFE Pharma MCC

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

SCIENTIFIC DISCUSSION

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

Wettable Magnesium Stearate. What Are Customers Looking for in Selecting Pharmaceutical Lubricants?

KING KHALID UNIVERSITY

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

Formulation and evaluation of sublingual tablets of lisinopril

Formulation and Evaluation

SCIENTIFIC DISCUSSION. Antimycobacterial (J04AC01).

Summary Public Assessment Report. Generics. Triflu Paracetamol, Ascorbic acid, Pheniramine maleate MT/H/0172/001/DC

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Excipient Considerations for Continuous Manufacturing Implementation

SCIENTIFIC DISCUSSION

BCS: Dissolution Testing as a Surrogate for BE Studies

3. Drug or plant or excipients profile

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Suppository Chapter Content

Soluplus The Solid Solution Opening New Doors in Solubilization.

Public Assessment Report. Scientific discussion. Acetylcysteine YES 600 mg, effervescent tablets. (acetylcysteine) NL/H/2975/001/DC

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

Determination of bioavailability

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Decentralised Procedure. Public Assessment Report. Zolmitriptan Renantos 2.5 mg Orodispersible film 5 mg Orodispersible film DE/H/2295/ /DC

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy

Public Assessment Report. Scientific discussion. Pentasa Compact 4 g, prolonged-release granules. (mesalazine) NL License RVG:

A New USP Tool The Class Monograph

A. General Appearance

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

Rationale of and Experience with the Expert System

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION. Darunavir

Public Assessment Report. Scientific discussion. Granon (Acetylcysteine) DK/H/2352/ /MR. Date:

SCIENTIFIC DISCUSSION

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

SCIENTIFIC DISCUSSION

Designed and manufactured specifically for pharmaceutical capsule filling

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

SCIENTIFIC DISCUSSION

Advanced functional coating solutions for nutraceuticals

AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN

SCIENTIFIC DISCUSSION

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Technical brochure StarLac

Biowaiver Study on Prednisolone Tablets 5 mg in Three Different Brands. Marketed in Sudan. Safaa Mohamed *, Tilal Elsaman

DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

TABLET DESIGN AND FORMULATION

what is Fibersol-2 AG?

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

Formulation and evaluation of oro-dispersible tablets of lafutidine

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

Development of Nutrient Delivery Systems: Ingredients & Challenges

SCIENTIFIC DISCUSSION

SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS. Dr. Jay T. Holt, Ph.D., Sr. Director, Inhalation & Analytical

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Abacavir (as sulfate) 300 mg tablets WHOPAR part 6 May 2016 (Hetero Labs Ltd), HA575

SCIENTIFIC DISCUSSION. Efavirenz

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

BASIC PHARMACOKINETICS

Research Article Preformulation Studies for Generic Omeprazole Magnesium Enteric Coated Tablets

Distribution of low dose drugs in granules: Influence of method of incorporation

SUMMARY AND CONCLUSION

Available Online through Research Article

Taking the guesswork out of supplying multi-compartment compliance aids: do pharmacists

Controlled Delivery of Biologics NBC 22 June 2009

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

Topics covered by the talk

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

WHOPAR. SCIENTIFIC DISCUSSION

GSC CODEX MESSAGE CCFA48/2016/25

Overview of Generic Drug Policy and Introduction of its Review Points/BE Guideline in Japan

CONTROLLED-RELEASE & SUSTAINED-RELEASE DOSAGE FORMS. Pharmaceutical Manufacturing-4

Volume 1(3) May-June 2013 Page 351

Bioavailability enhancement of poorly soluble APIs. Enhanced solubilization out of solid glassy solutions prepared by Hot-Melt Extrusion

skim milk as carrier by kneading method. They were evaluated for percentage yield, drug content, FT-IR

Current FDA Perspective on Excipients NJPhAST Meeting September 15, 2016

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

The Particle Design of Cellulose and the Other Excipients for a Directly Compressible Filler-Binder

SCIENTIFIC DISCUSSION

Transcription:

TABLET PRODUCTİON

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good quality at high standards. Based on preformulation studies, the optimal dosage forms are generally decided. When given orally, the solid dosage form tablet undergoes in vitro disintegration and dissolution followed by absorption through the gastrointestinal tract (GI). The in vivo biodistribution of drug which enters the systemic circulation then occurrs.

SELECTION OF PHARMACEUTICAL EXCIPIENTS A tablet contains active ingredients as well as other substances known as excipients, which have specific functions. A pharmaceutical excipient is defined as an inactive ingredient or any component other than the active ingredient added intentionally to the medicinal formulation or everything in the formulation except the active drug. Pharmaceutical excipients are also called additives, pharmaceutical ingredients, or inactive pharmaceutical ingredients.

There are many reasons for selecting and adding these pharmaceutical excipients in formulations. In the preparation of various dosage forms, it is essential to combine pharmaceutical excipients with model drugs as adjuvants to prepare the solid dosage forms, mainly tablets. The pharmaceutical excipients make the drug into the final dosage forms. Physicochemical properties such as solubility, stability, metabolism, and even bioavailability of drugs can be varied by the pharmaceutical excipients.

Pharmaceutical excipients are regarded as key ingredients not only to decide optimal dosage forms but also to change the physicochemical and biological parameters of drugs. With an aid of pharmaceutical excipients, drug efficacy can be maintained. Changes of other types of dosage forms for different routes of administration are also achieved. The excipients can also function for the preparation of dosage formulation during the manufacturing processes.

However, utilization of these pharmaceutical excipients is limited by the regulatory guidelines to be satisfied in the dosage formulations. In general, the regulatory guidelines require the following conditions for the use of excipients in the dosage formulations: (a) no harmful or toxicological effect and listed GRAS (generally recognized as safe), (b) good stability with no drug excipient incompatibility and by any impurities in the excipients, (c) no interference in quality validation and analytical tests, (d) satisfaction of regulatory issues and guidelines in all countries where the product is to be marketed, (e) no instability with primary packing materials, (f) ease of accessibility, distribution, and economical cost, (g) satisfaction for environmental issues, (h) be physiologically inert, (i) be physically and chemically compatible with the active substance and the other excipients in the formulation, and (j) no unacceptable microbiological burden.

Pharmaceutical Excipients Used in Tablet Formulations

The Classification of Tablet Manufacturing Methods granulation direct compression wet granulation: suitable for drugs that are stable to moisture and heat dry granulation: suitable for drugs that are sensitive to moisture and heat powder compression : suitable for drugs that are sensitive to moisture and heat, fill material possessing, good flowability and compressibility crystal compression:suitable for drugs with proper crystal form and good flowability

Single Punch Machine (Tablets) Upper and Lower Collar Collar locker

Operation of eccentric tableting machine: ( a ) filling; ( b ) compression; ( c ) ejection; ( d ) pushing from die table.